The discovery of immunostimulatory DNA sequence

Springer Seminars in Immunopathology

Volumn 22, Issue 1-2, 2000, Pages 11-19

  Yamamoto, Saburo ^a   Yamamoto, Toshiko ^a   Tokunaga, Tohru ^b  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b Fukuoka Jo Gakuin University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; DEOXYRIBONUCLEASE; PALINDROMIC DNA; STREPTOMYCIN SULFATE;

ANAPHYLACTIC SHOCK; ANTINEOPLASTIC ACTIVITY; BACILLUS SUBTILIS; CANCER IMMUNOTHERAPY; DNA DETERMINATION; DNA SEQUENCE; ESCHERICHIA COLI; GAS LIQUID CHROMATOGRAPHY; GUINEA PIG; MYCOBACTERIUM BOVIS; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PSEUDOMONAS PUTIDA; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOMYCES AUREOFACIENS; TUMOR GROWTH;

EID: 0033740574     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002810000019     Document Type: Review

References (29)

1. Isolation and properties of a macromolecular, water-soluble, immunoadjuvant fraction from the cell wall of Mycobacterium smegmatis
2. Biological active components from mycobacterial cell walls. I. Isolation and composition of cell wall skeleton and component P3
3. Bacillus Calmette-Guerin contact immunotherapy of local and metastatic deposits of rat tumors
4. CpG-rich islands and the function of DNA methylation
5. DNA immunotherapeutics: New potential treatment modalities for allergic disease
6. Water-soluble and lipid free fraction from BCG with adjuvant and antitumor activity
7. Anti-tumor activity of synthetic oligonucleotides with sequences from cDNA encoding proteins of Mycobacterium bovis BCG
8. CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge
9. CpG motifs in bacterial DNA trigger direct B cell activation
10. Therapy of tuberculosis in mice by DNA vaccination
11. Mycobacterial RNA: A comparison with intact mycobacteria for suppression of murine tumor growth
12. Mycobacterial cell wall fractions for regression of murine tumor growth
13. BCG immunotherapy of malignant melanoma: Summary of a seven-year experience
14. Immune activation by bacterial DNA: A new genetic code
15. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization
16. Antitumor activity of the DNA fraction from Mycobacterium bovis BCG. II. Effects on various syngeneic mouse tumors
17. Hexamer palindromic oligonucleotides with 5'-CG-3' motif(s) induce production of interferon
18. International conference on immunotherapy of cancer
19. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physico-chemical characterization and antitumor activity
20. A synthetic single-stranded DNA, poly(dG,dC), induces interferon-alpha/beta and -gamma, augments natural killer activity, and suppresses tumor growth
21. Synthetic oligonucleotides with particular base sequences from the cCNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate natural killer cells
22. Studies on the heterologous immunogenicity of a methanol-insoluble fraction of attenuated tubercle bacilli (BCG)
23. Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer activity
24. DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth
25. Lipofection of synthetic oligodeoxyribonucleotides having a palindromic sequence of AACGTT to murine splenocytes enhances interferon production and natural killer activity
26. Immunologic approaches to the treatment of human cancer based on a guinea pig model
27. CpG oligodeoxynucleotides trigger protective and curative Th1 response in lethal murine leishmaniasis